investigations of fatty liver
Last reviewed 05/2022
Initial laboratory tests include:
- liver enzymes
- aminotransferase levels
- in non alcoholic fatty liver disease –
- alanine aminotransferase (ALT) levels exceeding those of aspartate aminotransferase (AST) – AST:ALT <0.8 (>0.8 with more advanced disease)
- in alcoholic fatty liver disease
- AST:ALT ratio >1.5
- gamma glutamyl transferase (GGT)
- alkaline phosphatase (ALP) – may be increased
- MCV – increased
- raised MCV and serum gamma GT suggest alcohol abuse; note that GGT may be raised in non-alcoholic steohepatitis which is not associated with alcohol abuse
- hepatic screen for other causes of abnormal liver function tests including screening for hepatitis B, hepatitis C and haemochromatosis
- liver imaging
- ultrasound,
- is the first-line imaging technique
- causes increased echogenicity on ultrasound (compared with the lower echogenicity of the spleen or renal cortex)
- sensitivity and specificity of detecting fatty infiltration decreases as BMI increases
- CT or MRI will demonstrate fatty infiltration
- liver biopsy
- needle biopsy confirms the diagnosis and excludes irreversible disease
Additional laboratory tests may be considered in patients with chronically elevated liver enzyme levels or in those with a family history of cirrhosis and includes:
- autoimmune studies - antinuclear antibody, smooth muscle antibody
- α1-antitrypsin
- ceruloplasmin
- thyroid-stimulating hormone levels
- NICE suggest to consider using the enhanced liver fibrosis (ELF) test in people who have been diagnosed with non-alcoholic fatty liver disease (NAFLD) to test for advanced liver fibrosis (4)
Reference:
- (1) Wilkins T et al. Nonalcoholic fatty liver disease: diagnosis and management. Am Fam Physician. 2013;88(1):35-42.
- (2) Sattar N, Forrest E, Preiss D. Non-alcoholic fatty liver disease. BMJ. 2014;349:g4596
- (3) Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. CMAJ. 2005;172(7):899-905.
- (4) NICE (July 2016). Non-alcoholic fatty liver disease (NAFLD): assessment and management
enhanced liver fibrosis (ELF) score
assessment for advanced liver fibrosis in people with NAFLD